• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Nov. 9, 2025, 5:00 AM ESTBy Jonathan AllenIt’s not in President Donald Trump’s nature to accentuate the negative — at least not when it comes to his own performance or plans — and in the current moment, that has put him at risk of sounding out of touch with Americans who are struggling to make ends meet.“We had the greatest economy in the history of our country,” Trump said of his first term in an interview with Norah O’Donnell for CBS’ “60 Minutes” a week ago. “But my second term is blowing it away.”Two days later, voters blew away Republican candidates up and down the ballot in Virginia and New Jersey, results that reinforced NBC News polling showing that the vast majority of voters — about two-thirds — think the president hasn’t lived up to his promises to curb inflation and improve the economy. The common watchword for Democratic candidates who won on Tuesday — both progressives and centrists — was “affordability.”Look no further than Trump’s predecessor to see the peril for the president. Early in his single term, President Joe Biden ignored inflation, then his administration dismissed it as a “transitory” effect of government spending during the Covid-19 pandemic, before scrambling to minimize the political fallout of losing trust with the public.For Trump, who has described himself as a “cheerleader” for the country, his handling of the substance and messaging around affordability amounts to a bet that he’s on the right track — and can prove it quickly — even if most American voters don’t see it that way right now. Biden thought the same.“Trump has an enormous gamble,” said Newt Gingrich, a former House speaker and a Trump ally. He is betting that his economic policies — including tariffs, tax cuts and investments in the U.S. — will combine to create a “boom of extraordinary proportions” by next summer, Gingrich said in an interview.“If that’s true, Republicans are going to have a very good 2026,” Gingrich said of next year’s midterm elections. “If it’s not true, Republicans are going to have a very tough 2026.”Like Trump, Biden argued that the broader economy was strong, even as taxpayers suffered. And like Trump, Biden watched his party’s fortunes change at the ballot box a year after his own election.“As our economy has come roaring back, we’ve seen some price increases,” Biden said in July 2021. “Some folks have raised worries that this could be a sign of persistent inflation. But that is not our view. Our experts believe, and the data shows, that most of the price increases we’ve seen are expected to be temporary.”Trump hosts Gatsby-inspired Halloween party at Mar-a-Lago00:33In November of that year, 12 months after Biden won Virginia over Trump by 10 percentage points, Republican Glenn Youngkin won the state’s governorship by 2 percentage points. On Tuesday, Gov.-elect Abigail Spanberger, a Democrat, won Virginia by about 15 percentage points. NBC News exit polls showed that the economy was the top issue for 48% of voters — more than double the 21% who picked health care, which was the second-highest-ranking topic.Trump, who is collecting hundreds of millions of private dollars to build a White House ballroom and who hosted a “Great Gatsby”-themed Halloween party in the middle of the ongoing government shutdown, said this week that the costs of everyday life are not something he wants to address.“The reason I don’t want to talk about affordability is because everybody knows that it’s far less expensive under Trump than it was under ‘Sleepy Joe Biden,’ and the prices are way down,” he said of his predecessor in remarks to reporters last week.Trump is frustrated because he doesn’t believe he’s getting the credit he deserves for efforts to bring down prices, said one senior White House official who conceded that the administration is not doing a good enough job of communicating on affordability.Kornacki: How Mikie Sherrill swept New Jersey despite Trump’s 2024 gains15:16It’s clear that other Republicans are taking a cue from voters. In announcing her bid for governor of New York on Friday, Republican Rep. Elise Stefanik put the issue of affordability front and center. Rather than blame Trump, with whom she is close, Stefanik drew a bead on Democratic Gov. Kathy Hochul, who is seeking re-election.“The No. 1 issue is affordability,” Stefanik said in an interview with WHAM radio’s Bob Lonsberry. “New York is the most unaffordable state in the nation because of Kathy Hochul’s leadership.”And even if Trump won’t acknowledge it, his aides say that the White House is paying attention to the squeeze that families across the country say they’re feeling.“The president is very keyed in to what’s going on, and he recognizes, like anybody, that it takes time to do an economic turnaround, but all the fundamentals are there, and I think you’ll see him be very, very focused on prices and cost of living,” White House deputy chief of staff James Blair told Politico.But that, too, presents a messaging challenge for Trump, who is presiding over consumer prices that rose 3% in the 12 months ending at the close of September. He has the biggest megaphone in the country, and his own words — which sound a lot like Biden’s — may drown out anything his aides say.Many Democrats who served in the Biden White House remember a president who disagreed with voters on the strength of the economy and paid a price for failing to acknowledge the sentiments of the electorate.“The economic statistics may be great, and in President Biden’s case they were,” Democratic strategist Adrienne Elrod said in an exchange of text messages. “But when prices are too high and the messenger keeps saying ‘No, you’re wrong, the economy is actually fantastic,’ the messenger starts to lose credibility with voters.”Elrod, who worked for Biden on the campaign trail and in the White House, said Trump is making the same mistakes as Biden and Vice President Kamala Harris, who took his place at the top of the Democratic ticket in 2024.“You have to meet the voters where they are — never forget President Clinton’s effective use of the line ‘I feel your pain,’” she said. “Our failure to do that in 2024 is ultimately one of the reasons we lost the presidential election, and Trump’s failure to do that now is one of the reasons he is perpetually under water with voters on the economy.”Jonathan AllenJonathan Allen is a senior national politics reporter for NBC News. Peter Nicholas and Monica Alba contributed.

admin - Latest News - November 9, 2025
admin
19 views 14 secs 0 Comments




Even as Republicans have started to feel political heat on economic issues, Trump has continued to insist that the economy is better than ever.



Source link

TAGS:
PREVIOUS
Nov. 8, 2025, 9:56 AM ESTBy Erika EdwardsAltering a single gene may help people lower dangerously high levels of cholesterol and other fats in the blood, according to new research presented Saturday at the annual meeting of the American Heart Association in New Orleans.The Phase 1 clinical trial of 15 people was intended to show whether the experimental gene-editing therapy was safe to use in humans.It was, the researchers said. It was also effective: One infusion of the medicine drove down low-density lipoprotein (LDL) cholesterol and triglycerides by about half — an effect that could decrease patients’ heart disease risk for the rest of their lives.“Frankly, if you’d asked me 15 years ago if we would be able to do this, I would have thought you were crazy,” said Dr. Steven Nissen, chief academic officer at the Cleveland Clinic’s Heart, Vascular & Thoracic Institute and one of the study’s investigators. “The results were pretty spectacular.”The experimental drug employs CRISPR, a gene-editing tool that makes cuts and changes to the body’s genetic code. In this case, it manipulates a single gene in the liver that normally boosts cholesterol levels. Unlike cholesterol-lowering drugs like statins that need to be taken daily, this approach is meant to work permanently after one dose. (CRISPR Therapeutics makes the drug and helped fund the study.)The research, which was also published Saturday in The New England Journal of Medicine, created a mix of excitement and concern among cardiologists.“It’s a good proof-of-principle study, meaning we know we can do it,” said Dr. Karol Watson, co-director of the Program of Preventive Cardiology at UCLA Health. “It doesn’t answer the question, ‘Should we do it?’”The CRISPR technique would be considered a lifelong change in a person’s genetic makeup. As such, its long-term safety is unknown. Ongoing studies will need to make certain that the therapy doesn’t cause harm to the liver, where its effects are primarily seen.“Here’s the thing,” Watson said. “We already have really safe, really good medications that lower LDL and triglycerides that are easy, once-daily oral medications. They will have to show us that CRISPR is very effective and safe. Long-term safety will be key.”According to Nissen, however, about half of people prescribed daily statins stop using them within a year, often because they have side effects. Moreover, the clinical trial only included patients who had tried, without success, to lower their cholesterol through standard approaches.Dr. Nishant Shah, a preventive cardiologist at Duke University Medical Center in Durham, North Carolina, said the technology is far from being used in everyday practice “for good reason.”“These are long-lasting effects,” he said, “so we really need to make sure we understand safety before we can provide these therapies.”But if the drug is deemed to be safe, Shah said, “the future is very promising to be able to take care of patients at high risk for cardiovascular disease.”Heart disease is the No. 1 cause of death for Americans. The accumulation of fats in the blood including LDL cholesterol and triglycerides can clog arteries and lead to heart attack and stroke.About a quarter of U.S. adults, 25.5%, have dangerously high LDL levels of more than 130 mg/dL, according to the AHA. LDL levels below 100 mg/dL are considered healthy for most adults.The drug targets a gene called ANGPTL3, which tells the body to make a protein that prevents the liver from breaking down cholesterol. Some people have naturally low-functioning versions of this gene, resulting in lifelong reductions in LDL cholesterol and triglyceride levels, according to the study. The drug is meant to mimic this effect, by turning off the gene so the liver is able to break down more cholesterol and fats.The 15 trial participants lived in Australia, New Zealand and the U.K. They were in their 50s and 60s. Thirteen were men. All had uncontrolled high LDL, triglycerides or a combination of the two.At the beginning of the trial, the median LDL cholesterol level was 155 mg/dL, and the median triglyceride level was 192 mg/dL, far above what’s considered healthy (below 150 mg/dL).Participants got different doses of the treatment, called CTX310, in a single infusion that lasted up to 4 ½ hours. A few people had side effects like nausea or back pain during the infusion. One volunteer had a temporary spike in liver enzymes that eventually returned to normal. And one person died for an unrelated reason months after the infusion, researchers said.The highest dose was given to four participants. In those people, LDL cholesterol decreased by 48.9%, and triglycerides fell by 55.2% within two months of treatment.“What’s nice about this target of ANGPTL3 is that it not only lowers the LDL, the bad cholesterol, but it also has some effectiveness on people who have very high triglycerides,” said Dr. Elizabeth McNally, a human geneticist and cardiologist at the Northwestern Feinberg School of Medicine in Chicago.“This could be helpful, but it really does remain to be seen how this is better than existing therapies,” said McNally, who was not involved with the current research.This isn’t the first time an experimental gene therapy has proved successful at driving down cholesterol in early studies. Two studies presented at the AHA meeting in 2023 went after genes to lower cholesterol levels. Larger studies on those treatments are ongoing.CRISPR technology is relatively new, with excitement growing for the tool since it was first used in 2012. (Its inventors won the Nobel Prize in medicine in 2020.) In 2023, the Food and Drug Administration approved the first CRISPR drug in the U.S., Casgevy, which treats sickle cell disease.Nissen said the next phase of clinical trials on the CTX310 treatment will include more patients, including people in the U.S. “We’ve got a ways to go, but this is the door to the future,” he said.Erika EdwardsErika Edwards is a health and medical news writer and reporter for NBC News and “TODAY.”Kaan Ozcan contributed.
NEXT
Nov. 9, 2025, 5:02 AM ESTBy Andrew GreifIt’s the middle of the NFL season. Do you know who your Super Bowl contenders are? Good luck determining that. For the first time since 2010, every team has at least two losses through Week 9, according to research by NBC Sports. Further, of the league’s eight divisions, six have a team in first place either outright, or tied for first, that didn’t win it last year. One site that calculates playoff probabilities has pegged 10 teams with at least a 10% chance of making the Feb. 8 Super Bowl in Santa Clara, California. Everything feels wide open — with the exception of one division. And given the history of the NFC East, that’s a surprise.The NFC East hasn’t had a repeat division winner since 2003-04, making it an outlier in a league where division titles infrequently change hands. Last season’s champions of the AFC East, West, South and North and the NFC South and North all were repeat winners. And the only exception, the NFC West, last saw a repeat winner in 2022-23.Eight games still remain in the regular season, and though the Eagles are 6-2, they haven’t been the picture of dominance; one more loss will tie their season total from all of last year. Last year, their combination of an elite offensive line and running back led to a Super Bowl title while producing 179 rushing yards per game. This season, that average has dropped by 37 percent. The Eagles also are averaging nearly a full yard less per carry. Still, it’s not too early to suggest that Philadelphia is primed to finally produce a repeat champ in the NFC East. That’s because what was one of last season’s strongest divisions — it produced both conference finalists, in the Eagles and Washington Commanders — has fallen apart. Dallas (3-5-1), Washington (3-6) and New York (2-7) all have losing records, are currently on losing streaks and have been outscored on the season. The chances any of the three threatens a comeback could be slim; the Eagles have just three divisional games remaining. What else we’re watching in Week 10Falcons (3-5) at Colts (7-2): The NFL’s first game played in Berlin features two elite running backs: Atlanta’s Bijan Robinson (1.058 yards from scrimmage) and Indianapolis’ Jonathan Taylor (1,113). But Taylor was held to a season-low 45 rushing yards last week in a loss.Saints (1-8) at Panthers (5-4): Carolina quarterback Bryce Young has won his last four starts, and running back Rico Dowdle’s 735 yards are third-most in the league.Giants (2-7) at Bears (5-3): The Giants have lost 10 straight road games. The Bears have won five of their last six. Jaguars (5-3) at Texans (3-5): With quarterback C.J. Stroud (concussion) sidelined, Houston’s Davis Mills will start for the first time since 2022. He’ll be supported by the league’s best defense in yards (267) and points (15.1) allowed per game.Bills (6-2) at Dolphins (2-7): Buffalo has won 14 of its last 15 games against Miami, which has scored 10 points or less three times this season.Ravens (3-5) at Vikings (4-4): It’s hard to believe but Justin Jefferson’s touchdown catch last week was his first since Week 1. With 76 yards, Jefferson will pass Torry Holt for the most receiving yards through a player’s first six seasons.Browns (2-6) at Jets (1-7): New York’s rebuilding defense plays for the first time since trading Pro-Bowlers Quinnen Williams and Sauce Gardner. Cleveland has lost 12 consecutive road games.Patriots (7-2) at Buccaneers (6-2): Both teams are off to their best start since each was quarterbacked by Tom Brady: 2021 for Tampa Bay, and 2019 for New England.Cardinals (3-5) at Seahawks (6-2): Seattle has won eight straight games in this matchup. Rams (6-2) at 49ers (6-3): A key game in the race for the NFC West crown, where these teams and the Seahawks all have six wins. The Rams have allowed a minuscule 6.7 points per game during their three-game winning streak.Lions (5-3) at Commanders (3-6): Detroit has won 12 straight games coming off of a loss, dating to 2022. To win again, they’ll need Jahmyr Gibbs and David Montgomery to produce more than the 65 rushing yards they combined for last week. Steelers (5-3) at Chargers (6-3): A Steelers defense that just forced six turnovers now faces Justin Herbert, whose 2,390 passing yards and 18 passing touchdowns are second-most in the league. Eagles (6-2) at Packers (5-2-1): On Monday night, the key is turnovers. Green Bay has given the ball away just five times all season. The only team with fewer? Green Bay, with three. Andrew GreifAndrew Greif is a sports reporter for NBC News Digital. 
Related Post
October 28, 2025
Trump says he had an MRI during October checkup
September 24, 2025
Witness says she took cover after hearing gunshots at Dallas ICE facility 
September 25, 2025
Colombian miners rescued after two days underground
October 27, 2025
Oct. 27, 2025, 2:55 PM EDTBy Minyvonne Burke and David K. LiThe federal case against NBA guard Terry Rozier — accused of faking an injury during a game to tip off bettors — has exposed what sports medicine experts say is an unforeseen blind spot.Do teams have any other choice but to trust players to tell the truth about how they feel?“If the player says he can’t go in the first quarter, he doesn’t go,” former Dallas Mavericks team physician Tarek Souryal told NBC News last week. “We can’t see pain. You can see swelling. You can see bruising. You can see a cut. But you can’t see pain.”Rozier, 31, was charged Thursday with conspiracy to commit wire fraud and money laundering.Federal prosecutors allege he feigned a right foot injury while playing for the Charlotte Hornets during a March 23, 2023, game in New Orleans, after telling a friend beforehand he planned to bench himself early. The friend then sold that “non-public information” to bettors, according to the indictment. Rozier, now with the Miami Heat, has denied any wrongdoing. His attorney, Jim Trusty, said his client “is not a gambler” and “looks forward to winning this fight.”The case has renewed scrutiny on how the NBA verifies injuries and whether the rise of legalized sports betting has made players’ health status the newest vehicle of inside information.A fateful night in New OrleansRozier logged 35.3 minutes per game in 2022-23 for Charlotte but, on that late-March evening in New Orleans, he lasted for just 9½ minutes of action.After hitting a jumper from the free-throw line with about 6 ½ minutes left in the first period, Rozier hobbled and grabbed at his right foot in distress.Rozier did not appear to land awkwardly when he hit that jumper or show any other discomfort in the moment ahead of the shot.Federal prosecutors claimed that Rozier was actually feigning that injury in front of an arena full of paying, unsuspecting fans. Behind the scenes, Rozier’s friend had raked in tens of thousands of dollars from selling the information, according to the indictment.About a week later, the friend drove to Rozier’s Charlotte home so they could count the money, prosecutors said.In an internal memo sent Monday to all 30 NBA teams, the league said it was reviewing policies on injury reporting and how personnel are trained. It was also looking into ways to enhance “internal and external integrity monitoring programs,” the memo, obtained by NBC News, read. The NBA previously said it investigated unusual activity around the Hornets-Pelicans game but “did not find a violation of NBA rules.” The league said it is cooperating with the U.S. Attorney’s Office for the Eastern District of New York.NBA Commissioner Adam Silver said Friday he was “deeply disturbed” by the allegations.“There’s nothing more important to the league and its fans than the integrity of the competition,” Silver said. “And so I had a pit in my stomach. It was very upsetting.”The NBA insists, though, that there was documentation of Rozier’s injury 2½ years ago.“Any assertion that the NBA had anything to do with Terry Rozier not playing games following his departure from the game on March 23, 2023, is categorically false,” according to a league statement. “Per team doctors, Rozier had a real foot injury confirmed with an MRI.”Rozier’s indictment was part of a broader probe that also charged Portland Trail Blazers coach Chauncey Billups and former player and coach Damon Jones in a separate mob-linked poker cheating scheme.How are injuries assessed?The NBA says that teams “must report information concerning player injuries, illnesses, other medical conditions, or rest for all games [by] 5 p.m. local time the day before a game.”In addition, the policy says, teams must “designate a participation status and identify a specific injury, illness, other medical condition, or other reason for any player whose participation in the game may be affected for any reason.”But Souryal said there is “no league-wide rule on how injuries are assessed.” “Each team does it different. Every doctor does it different,” he said. Trainers are the first to evaluate a player, but the athlete has the “ultimate last say” on whether he plays, Souryal added.Art Caplan, who heads the division of medical ethics at New York University, said team doctors have no way to independently verify claims of pain during a game.“‘Pete’ comes off the court and says my heel hurts or my knee is killing me, you take that seriously on the spot as something that he’s telling the truth,” Caplan said. “In that setting of sports, the athlete’s complaint literally drives what happens.”Who has the ‘ultimate last say’?Souryal said athletic trainers are typically the first to evaluate an injured player. Depending on the severity of the injury, the team physician will be notified to do another evaluation and order any necessary testing, Souryal said.“If it happens on the court, then you evaluate him on the court, you get him to the locker room, you evaluate him again in the locker room,” he said. “But if it’s one of those things where ‘Player X’ is complaining of hamstring pain, that’s something that can be assessed during halftime or after the game. There is no protocol.”Souryal said that most teams follow the same “chain of command,” except when a player says he’s injured to the point where he cannot play in a game.Even if an X-ray shows no signs of a serious injury, Souryal said the player “has the ultimate last say” on whether he hits the court.While the allegations against Rozier have led to speculation about his injury, Souryal said he does not think the Hornets could have done anything differently.“We always have to take the player’s word as medical staff, and given the time and the setting and the situation, I don’t know that anything differently could have been done by the team or the staff,” he said.Rozier was placed on immediate leave from the Miami Heat following his arrest. ‘Injuries’ play role in gamesmanshipFaking an injury isn’t completely foreign to big-time sports, though it’s usually done for competitive edge and not to throw a game or prop wager.Modern offenses in pro and major college football often run high-tempo attacks, prompting some defenders to feign injury just to slow down an opponent’s pace.In late 2022, the NFL went as far as to threaten teams with heavy fines and lost draft picks to stop the practice.In college football last month, the Atlantic Coast Conference fined Syracuse $25,000 for feigning injuries in a victory over Clemson.The role of gambling in NBARozier’s case isn’t the first time an NBA player has been accused of consorting with gamblers since a landmark 2018 Supreme Court ruling opened the floodgates to legalized sports wagering.In 2024, the league banned Toronto Raptors forward Jontay Porter alleging that he bet on games, passed on information to gamblers and claimed illness to influence a wager.The NBA said its investigation found that Porter had engaged in widespread gambling, against league rules.It alleged that he “disclosed confidential information” about his own health status to an individual he knew to be an NBA bettor” before a March 20, 2024, game.Porter claimed to suffer from an illness during the game and played only three minutes, the league said.“When sports gambling first came into sports … I always thought that how injuries are handled was going to be a potential problem,” Souryal, the former Mavs team doctor, said.An $80,000 online bet that he would underperform was placed ahead of that game, which would have paid out $1.1 million. The conspicuously large amount led to the wager’s being “frozen” and “not paid out,” the NBA said.Rozier’s attorney, Trusty, insists his client has done nothing wrong and accused federal authorities of grandstanding.“We got a trophy hunt, so we’re going to fight it,” Trusty said.Minyvonne BurkeMinyvonne Burke is a senior breaking news reporter for NBC News.David K. LiSenior Breaking News ReporterPhil Helsel, Doha Madani and Rohan Nadkarni contributed.
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved